0845 GMT - Alcon's reiteration of its full-year guidance is likely to offer relief to investors, given fears that the outlook could be downgraded, J.P. Morgan analysts say in a research note. The Swiss eyecare company confirmed its expectations for sales, profitability and core earnings, and still expects a tariff impact of about $100 million that it aims to fully offset. The market was concerned guidance could be lowered, according to J.P. Morgan. Alcon's sales were in line with expectations and core operating margins better than forecast, the analysts say. Shares in Switzerland climb 6.3%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

November 12, 2025 03:46 ET (08:46 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.